Skip to main content

Posts

Showing posts with the label pre-market movers

Featured Post

Market Daily Report: Bursa Malaysia Ends Nearly Flat As Construction Stocks Attract Buying

 KUALA LUMPUR, Sept 8 (Bernama) -- Bursa Malaysia closed almost flat on Tuesday as buying interest rotated away from index heavyweights towards smaller-cap construction stocks, with sentiment affected by geopolitical uncertainty, said an analyst. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) eased 0.39 of a point to 1,714.40 from Monday’s close of 1,714.79. The benchmark index opened 1.65 points lower at 1,713.14 and moved between 1,710.44 and 1,714.50 throughout the trading session. The broader market was almost evenly balanced, with decliners leading gainers 548 to 546, while 598 counters were unchanged, 1,107 were untraded and 25 were suspended. Turnover expanded to 4.13 billion units valued at RM3.14 billion from 3.60 billion units valued at RM2.45 billion on Monday.

Pre-Market Movers: Earnings Winners Pop, Guidance Misses Get Punished

Quick Summary Earnings beats and upgrades are driving sharp upside gaps Weak guidance and regulatory risk are triggering heavy sell-offs Tech, healthcare and AI-linked names dominate volatility Gapping Up  Quince Therapeutics +81.7% Appointed LifeSci Capital to explore  strategic alternatives and restructuring Credo Technology +14.5% Issued  preliminary Q3 revenue well above guidance Ferrari +10.8% Q4 earnings beat  and order book now stretches to  end-2027 Entegris +9.5% Beat Q4 results and  guided Q1 above consensus Spotify Technology +8.5% Earnings beat , strong premium subscriber growth, and  margin improvement Datadog +7.0% Q4 beat and  Q1 revenue guidance topped estimates Oscar Health +6.6% Issued  strong FY26 revenue and operating earnings outlook Vistra Energy +4.2% Upgraded to  Buy  by Jefferies Unity Software +3.6% Oppenheimer upgrade to  Outperform Astera Labs +3.5% Ahead of earnings and announced  new AI design...

Today's Pre-Market Movers and Top Ratings

  Gapping Up: FedEx (FDX.US):  Stock surged  8.6%  after the company exceeded fiscal Q2 earnings expectations and announced plans to spin off its freight business. Eli Lilly and Co (LLY.US):  Shares climbed  5.5% , buoyed by increasing confidence in its  obesity treatments competing in a high-demand market. Gapping Down: Nike (NKE.US):  Shares dropped  7.4%  despite strong Q2 results, as the company highlighted  guidance concerns linked to "severe issues." Novo-Nordisk A/S (NVO.US):  Fell  18%  after its next-gen obesity drug  CagriSema  delivered  weight loss results below expectations in a late-stage trial. Tesla (TSLA.US):  Declined  5% , impacted by a  40.9% drop  in European Union registrations in November compared to last year. Trump Media & Technology (DJT.US):  Slipped  5.5%  after an SEC filing revealed Donald Trump transferred his stake in the company int...